Recent submissions

Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b COSMIC-021 Study

Neal, Joel; Lim, Farah Louise; Fang, Bruno; Torres Lozada, Patricia; Santoro, Armando; Gonzalez-Cao, Maria; FELIP, ENRIQUETA (Publication date: 2024-10-31)

Cabozantinib; Immunotherapy; Non-small cell lung cancer

Swarm learning with weak supervision enables automatic breast cancer detection in magnetic resonance imaging

Saldanha, Oliver Lester; Zhu, Jiefu; Müller-Franzes, Gustav; Carrero, Zunamys; Payne, Nicholas; Escudero, Lorena; Perez-Lopez, Raquel (Publication date: 2025-04-01)

Swarm learning; Breast cancer; Magnetic resonance imaging

Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials

Fernandez-Martinez, Aranzazu; Pascual, Tomás; Singh, Baljit; Nuciforo, Paolo; Rashid, Naim U.; Ballman, Karla (Publication date: 2023-05-10)

Càncer de mama; Expressió gènica

Multi-laboratory experiment PME11 for the standardization of phosphoproteome analysis

Colome Calls, Núria; Abian, Joaquin; Aloria, Kerman; Arizmendi, Jesus M; Barcelo-Batllori, Silvia; Braga-Lagache, Sophie; Martín Castel, Luna; Canals Suris, Francesc (Publication date: 2023-06-07)

Phosphoproteome

HMGA1, Moonlighting Protein Function, and Cellular Real Estate: Location, Location, Location!

Pujals-Pruneda, Mireia; Resar, Linda; Villanueva Cardús, Josep (Publication date: 2022-06-16)

HMGA1; Secretome; Unconventional protein secretion

The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain

Vera, Ruth; Labiano Ciriza, Ibone; Lecumberri, A.; Huerta, A. E.; Arasanz, Hugo; Ruiz Pace, Fiorella; Viaplana, Cristina; Dienstmann, Rodrigo; Castro, Natalia (Publication date: 2024-06-07)

Gastrointestinal cancer; Environmental risk factors; Precision medicine

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment

Espin Garcia, Roderic; Medina-Jover, Ferran; Sigüenza-Andrade, Javier; Farran Matas, Sònia; Mateo, Francesca; Figueras, Agnès; Serra, Violeta (Publication date: 2025-04-22)

Transcriptional regulation; Cancer treatment

Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer

Fiascarelli, Alessio; Merlino, Giuseppe; Capano, Stefania; Talucci, Simone; Bisignano, Diego; Bressan, Alessandro; Arribas, Joaquin (Publication date: 2023-07-06)

PI3K inhibitor; PIK3CA mutations; Trastuzumab resistance

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development

Martins-Branco, Diogo; Rodrigues Beal, Juliana; Coleman, Niamh; Westphalen, Benedikt; Cardone, Claudia; Schram, Alison; GARRALDA, Elena; Mateo, Joaquin (Publication date: 2024-11-19)

Drug development; Molecular targeted therapy; Tumour-agnostic

gcProfileMakeR: An R Package for Automatic Classification of Constitutive and Non-Constitutive Metabolites

Pérez Sanz, Fernando; Ruiz-Hernández, Victoria; Terry, Marta I.; Arce Gallego, Sara; Weiss, Julia; Navarro Lorente, Pedro Javier; Egea-Cortines, Marcos (Publication date: 2022-06-08)

Circadian clock; Constitutive metabolome; Machine learning

Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study

Bhatia, Shailender; Topalian, Suzanne; Sharfman, William; Meyer, Tim; Steven, Neil; Lao, Christopher D.; Fariñas-Madrid, Lorena (Publication date: 2025-03-21)

Nivolumab; Carcinoma de células de Merkel; Metástasis

Comparison of Neurite Orientation Dispersion and Density Imaging and Two-Compartment Spherical Mean Technique Parameter Maps in Multiple Sclerosis

Johnson, Daniel; Ricciardi, Antonio; Prados, Ferran; Collorone, Sara; Brownlee, Wallace; Grussu, Francesco; Kanber, Baris (Publication date: 2022-03-22)

Microestructura; Esclerosi múltiple; Tècnica de mitjana esfèrica

Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiative

Raicevic Toungouz, Gordana; Kamal, Maud; Gausachs Romero, Mireia; mazzarella, luca; Alessandrello, Rossana; Giacomini, Patrizio; Gonzalo Ruiz, Javier (Publication date: 2025-09-05)

Comprehensive genomic profiling; Liquid biopsy; Precommercial procurement

Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study

de la Cruz-Merino, Luis; Gion, María; Cruz Jurado, Josefina; Quiroga, Vanesa; Andrés, Raquel; Moreno, Fernando; Cortés Castan, Javier (Publication date: 2022-06-03)

Bomarkers; Breast cancer; Pembrolizumab

Sweet and Sour Ehrlichia: Glycoproteomics and Phosphoproteomics Reveal New Players in Ehrlichia ruminantium Physiology and Pathogenesis

Marcelino, Isabel; Colome Calls, Núria; Holzmuller, Philippe; Lisacek, Frédérique; Reynaud, Yann; Canals Suris, Francesc (Publication date: 2019-05-24)

Ehrlichia ruminantium; N-glycoproteins; O-GlcNAcylated proteins

The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer

Mayer, Ingrid; Winer, Eric; Linden, Hannah; Ma, Cynthia X.; Parker, Barbara A.; Bellet Ezquerra, Meritxell; Bardia, Aditya (Publication date: 2023-04-11)

Metastatic breast cancer; Postmenopausal

Considerations and recommendations from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 3—Ex vivo imaging: Data processing, comparisons with microscopy, and tractography

Schilling, Kurt; Howard, Amy; Ianus, Andrada; Hansen, Brian; Barrett, Rachel L. C.; Grussu, Francesco (Publication date: 2025-04-22)

Diffusion MRI; Ex vivo; Tractography

Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation

Gámez‑Chiachio, Manuel; Molina‑Crespo, Ángela; Ramos Nebot, Carmen; Martinez‑Val, Jeannette; Martinez, Lidia; Gassner, Katja; Arribas López, Joaquin Vicente; Bernadó Morales, Cristina (Publication date: 2023-04-19)

Gasdermin B; HER2 breast cancer; Protective autophagy

Hierarchical chromatin organization detected by TADpole

Soler-Vila, Paula; Cusco Pons, Pol; Farabella, Irene; Di Stefano, Marco; Marti-Renom, Marc A. (Publication date: 2021-11-05)

Mètodes computacionals; Genòmica

Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma

Ernst, Matthew; Navani, Vishal; Wells, Connor; Donskov, Frede; Basappa, Naveen; Labaki, Chris; Suárez, Cristina (Publication date: 2023-06-26)

Immunotherapy; Prognostication; Metastatic renal cell carcinoma

Articles científics - VHIO: Recent submissions

Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b COSMIC-021 Study ﻿

Swarm learning with weak supervision enables automatic breast cancer detection in magnetic resonance imaging ﻿

Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials ﻿

Multi-laboratory experiment PME11 for the standardization of phosphoproteome analysis ﻿

HMGA1, Moonlighting Protein Function, and Cellular Real Estate: Location, Location, Location! ﻿

The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain ﻿

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment ﻿

Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer ﻿

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development ﻿

gcProfileMakeR: An R Package for Automatic Classification of Constitutive and Non-Constitutive Metabolites ﻿

Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study ﻿

Comparison of Neurite Orientation Dispersion and Density Imaging and Two-Compartment Spherical Mean Technique Parameter Maps in Multiple Sclerosis ﻿

Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiative ﻿

Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study ﻿

Sweet and Sour Ehrlichia: Glycoproteomics and Phosphoproteomics Reveal New Players in Ehrlichia ruminantium Physiology and Pathogenesis ﻿

The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer ﻿

Considerations and recommendations from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 3—Ex vivo imaging: Data processing, comparisons with microscopy, and tractography ﻿

Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation ﻿

Hierarchical chromatin organization detected by TADpole ﻿

Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma ﻿